NTGN - Neon Therapeutics reports Q4 results March, 11 2019 08:47 AM Neon Therapeutics Inc. Neon Therapeutics (NASDAQ:NTGN): Q4 GAAP EPS of -$0.84. Cash, cash equivalents and marketable securities $103.3M Press Release More news on: Neon Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, ,